Resmed launches Sleep Institute to inform innovation in sleep health

SAN DIEGO – Resmed has launched the Sleep Institute, a global clinical insights initiative dedicated to advancing the science and understanding of sleep health. 

The company says the Sleep Institute partners with clinicians, researchers, policymakers and health system leaders to deliver objective, non-commercial, evidence-based insights that help inform care innovation, support policy decisions and elevate sleep as a global health priority.  

“Sleep Institute reflects Resmed’s commitment to advancing sleep health worldwide,” said Kimberly L. Sterling, vice president, health research at Resmed, on behalf of Sleep Institute. “It’s about moving from awareness to action – giving global health and policy leaders the insights they need to close today’s care gaps and shape tomorrow’s sleep medicine.” 

New findings from a U.S. consumer survey conducted by Sleep Institute highlight this need. While more than four in five respondents said sleep is important to their overall health, only one in three reported that a doctor or nurse has asked them about their sleep in the past six months. The institute says this disconnect illustrates the need to better integrate sleep into routine health care and policy discussions, a central focus of its work. 

Global collaboration at World Sleep Congress 

The Sleep Institute will debut at the World Sleep Congress, Sept. 5-10 in Singapore, with an expert-led symposium tackling one of sleep medicine’s most pressing challenges: the global underdiagnosis of OSA. The session will examine barriers in diagnostic pathways for OSA and highlight scalable solutions to help improve access and outcomes. 

The symposium, OSA Underdiagnosis – A world of difference, a common challenge, brings together clinical leaders from Iceland, Singapore, the United States and Sweden, including: 

• Erna Sif Arnardóttir – director, Reykjavik University Sleep Institute; president, European Sleep Research Society (Iceland) 

• Chi-Hang Ronald Lee – professor of medicine, National University of Singapore; senior consultant, National University Heart Centre and Alexandra Hospital (Singapore) 

• Michelle R. Zeidler – professor of medicine, University of California, Los Angeles (UCLA); director, VA Greater Los Angeles Sleep Center (U.S.) 

• Ludger Grote – medical director, Sleep Disorders Center, Sahlgrenska University Hospital (Sweden) 

“There is a clear and urgent need to close the diagnosis gap in sleep disorders such as OSA,” said Zeidler, MD. “Sleep Institute’s focus on translating evidence into action will help clinicians, policymakers, and health systems take meaningful steps toward earlier detection and more personalized care.”